Literature DB >> 35320534

Molecular Imaging for In Vivo Tracking and Detection of Galectin Binding Partners.

Thais Canassa De Leo1, Sofia Nascimento Dos Santos2, Emerson Soares Bernardes2, Richard D Cummings3, Sean R Stowell3,4, Marcelo Dias-Baruffi5.   

Abstract

Molecular imaging (MI) is a non-invasive growing technology that allows the investigation of cellular and molecular processes in basic and clinical research and medicine. Luminescent proteins and radionuclides can be associated to target molecules providing high-definition and real-time image of whole body in few minutes or hours. Several MI studies have enabled the determination of molecular partners, in vivo tracking, and fate of compounds in different disorders. Considering that galectins are multifaceted proteins with great impact in many biological events, here we describe methods and strategies to generate labeled galectins for in vivo non-invasive imaging studies.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bioluminescence; Galectin probes; Galectin-3; Molecular imaging; Radiolabeling

Mesh:

Substances:

Year:  2022        PMID: 35320534     DOI: 10.1007/978-1-0716-2055-7_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  21 in total

1.  Use of radiolabeled compounds in drug metabolism and pharmacokinetic studies.

Authors:  Emre M Isin; Charles S Elmore; Göran N Nilsson; Richard A Thompson; Lars Weidolf
Journal:  Chem Res Toxicol       Date:  2012-02-28       Impact factor: 3.739

2.  Whole-animal imaging: The whole picture.

Authors:  Monya Baker
Journal:  Nature       Date:  2010-02-18       Impact factor: 49.962

3.  Evidence for a role for galectin-1 in pre-mRNA splicing.

Authors:  A Vyakarnam; S F Dagher; J L Wang; R J Patterson
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

Review 4.  PET imaging of oestrogen receptors in patients with breast cancer.

Authors:  Michel van Kruchten; Elisabeth G E de Vries; Myles Brown; Erik F J de Vries; Andor W J M Glaudemans; Rudi A J O Dierckx; Carolien P Schröder; Geke A P Hospers
Journal:  Lancet Oncol       Date:  2013-10       Impact factor: 41.316

5.  Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation.

Authors:  Diana Hernández-Romero; Juan Antonio Vílchez; Álvaro Lahoz; Ana I Romero-Aniorte; Eva Jover; Arcadio García-Alberola; Rubén Jara-Rubio; Carlos M Martínez; Mariano Valdés; Francisco Marín
Journal:  Sci Rep       Date:  2017-01-12       Impact factor: 4.379

6.  Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation.

Authors:  Sofia Nascimento Dos Santos; Helen Sheldon; Jonathas Xavier Pereira; Christopher Paluch; Esther M Bridges; Márcia Curry El-Cheikh; Adrian L Harris; Emerson Soares Bernardes
Journal:  Oncotarget       Date:  2017-07-25

7.  Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity.

Authors:  Enrique Corapi; Gustavo Carrizo; Daniel Compagno; Diego Laderach
Journal:  Front Immunol       Date:  2018-09-26       Impact factor: 7.561

8.  Serum galectins as potential biomarkers of inflammatory bowel diseases.

Authors:  Tony B Yu; Susanna Dodd; Lu-Gang Yu; Sreedhar Subramanian
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

Review 9.  Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity.

Authors:  Santiago P Mendez-Huergo; Pablo F Hockl; Juan C Stupirski; Sebastián M Maller; Luciano G Morosi; Nicolás A Pinto; Ana M Berón; Jorge L Musuruana; Gustavo G Nasswetter; Javier A Cavallasca; Gabriel A Rabinovich
Journal:  Front Immunol       Date:  2019-01-09       Impact factor: 7.561

Review 10.  Monoclonal antibody-based molecular imaging strategies and theranostic opportunities.

Authors:  Niels Dammes; Dan Peer
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.